Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
10.45
+0.06 (0.58%)
Nov 4, 2024, 1:09 PM EST - Market open
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $1.63 billion as of November 4, 2024. Its market cap has increased by 786.50% in one year.
Market Cap
1.63B
Enterprise Value
1.24B
1-Year Change
786.50%
Ranking
Category
Stock Price
$10.45
Market Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $1.63B, an increase of 502.36%. That is a compound annual growth rate of 19.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 1.62B | 357.37% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.70B |
| Certara | 1.65B |
| Myriad Genetics | 1.63B |
| AtriCure | 1.63B |
| Kiniksa Pharmaceuticals International, | 1.62B |
| Harrow | 1.62B |
| Syndax Pharmaceuticals | 1.62B |
| NewAmsterdam Pharma Company | 1.60B |